Insider · CIK 0001718019
Donald Notman
cooofficer
Files at OCUL (OCULAR THERAPEUTIX, INC). First filing Sep 4, 2025, latest Sep 2, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $229k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OCUL: OCULAR THERAPEUTIX, INC
OCULOct 9, 2026 · close 7.54
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | OCULsell OCULAR THERAPEUTIX, INC | $11k 1,099 shares | -0% | - | |
| 45Moderate | OCULAR THERAPEUTIX, INC | $103k 11,446 shares | -3% | +53% from low-44% from high | |
| 45Moderate | OCULAR THERAPEUTIX, INC | $101k 11,490 shares | -3% | +54% from low-43% from high | |
| 30Weak | OCULAR THERAPEUTIX, INC | $13k 1,066 shares | -0% | +114% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock | -1,099 | $10.24 | $11k | 366,529 | 40 d ago |
| Feb 12, 2026 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock | -11,446 | $9.04 | $103k | 366,356 | Feb 17, 2026 |
| Feb 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock | -5,455 | $9.14 | $50k | 383,837 | Feb 4, 2026 |
| Feb 4, 2026 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock | -6,035 | $8.54 | $52k | 377,802 | Feb 4, 2026 |
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Common Stock | +79,112 | $0.00 | $0 | 389,292 | Jan 6, 2026 |
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Stock Option (Right to Buy)derivative | +240,932 | $0.00 | $0 | 240,932 | Jan 6, 2026 |
| Sep 2, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock | -1,066 | $12.43 | $13k | 308,807 | Sep 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.